Wedbush Expects Stronger Earnings for Dianthus Therapeutics
Dianthus Therapeutics, Inc. (NASDAQ:DNTH – Free Report) – Equities researchers at Wedbush lifted their Q2 2025 earnings estimates for Dianthus Therapeutics in a research report issued to clients and investors on Tuesday, May 13th. Wedbush analyst L. Chico now forecasts that the company will earn ($0.77) per share for the quarter, up from their previous […]
Dianthus Therapeutics, Inc. (NASDAQ:DNTH – Free Report) – Equities researchers at Wedbush lifted their Q2 2025 earnings estimates for Dianthus Therapeutics in a research report issued to clients and investors on Tuesday, May 13th. Wedbush analyst L. Chico now forecasts that the company will earn ($0.77) per share for the quarter, up from their previous […]
